Aging kidney is associated in humans and rodents with polyuria and reduced urine concentrating ability. In senescent female WAG/Rij rats, this defect is independent of arginine-vasopressin (AVP)/V 2 receptor/cAMP pathway. It has been attributed to underexpression and mistargeting of aquaporin-2 (AQP2) water channel in the inner medullary collecting duct (IMCD). We showed previously that dDAVP administration could partially correct this defect. Since AQP2 can also be regulated by AVPindependent pathways in water deprivation (WD), we investigated AQP2 and phosphorylated AQP2 (p-AQP2) regulation in thirsted adult (10-month-old) and senescent (30-month-old) female WAG/Rij rats. Following two-day WD, urine flow rate decreased and urine osmolality increased in both groups.
INTRODUCTION
Urine concentration in kidney requires water reabsorption mediated by aquaporin (AQP) water channels. In the collecting duct, this process is controlled by the antidiuretic hormone argininevasopressin (AVP) that binds to V 2 receptors and induces cytosolic cyclic AMP (cAMP) accumulation, phosphorylation of AQP2 by protein kinase A (PKA) at Ser 256, and insertion of AQP2 into the apical plasma membrane of principal cells (27) . Both water deprivation (WD) and AVP administration result in long-term upregulation of AQP2 expression in kidney collecting duct (44).
In humans and rodents, urine concentrating ability declines with age, resulting in polyuria and lower urine osmolality (14, 27, 30). In some strains of rats, this defect has been attributed to loss of nephrons or impaired AVP secretion (45, 50). In contrast, senescent female WAG/Rij rats exhibit impaired urinary concentration with no kidney disease, no decrease in AVP plasma level, no defect in V 2 receptor mRNA expression, and no change in the medullary cAMP content (17, 25, 35) . In this strain, reduced kidney concentrating capacity with aging has been attributed to: (i) underexpression of AQP2 and impaired targeting of both AQP2 and phosphorylated AQP2 (p-AQP2) within the cytoplasm of principal cells (11, 12, 46) , resulting in decreased water reabsorption in the inner medulla; (ii) lower cortico-papillary osmotic gradient resulting from papillary hypotonicity due, at least in part, to low urea content and underexpression of urea transporters in the inner medulla (11, 12, 47).
We have previously suggested that, despite proper AVP signaling, the threshold for AQP2 upregulation by AVP is higher in senescent rats than in adults. Indeed, administration of the V 2 receptor agonist dDAVP to old animals is sufficient to bring AQP2 expression back to control values (12). Furthermore, long-term food restriction is also associated with a higher plasma AVP level, which prevents the polyuria of senescent rats (11). Nevertheless, dDAVP-stimulation does not completely correct urine concentration in senescent animals, suggesting that molecular mechanisms other than the AVP-signaling pathway might be involved in the age-related concentrating defect.
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Plasma AVP concentration and osmolality. Animals were sacrificed by decapitation at the end of the two day-WD period and trunk blood was rapidly collected and centrifuged at 4°C. Plasma AVP concentration was measured by RIA with antiserum K9-IV (24) (gift of Dr L. C. Keil, NASA Ames Research Center, Moffett Field CA, USA) and 125 I-labeled iodo-AVP (17, 24). The minimum sensitivity of the assay was 0.25 pg/assay. For each animal, determination of plasma AVP concentration was performed in triplicate with independent standard curves. Plasma osmolality was measured on the same samples with a Fiske One-Ten osmometer.
Papilla cAMP and cGMP contents. Animals were killed by decapitation and the kidneys were quickly excised and chilled in ice-cold PBS. The white papilla was excised from both kidneys of each rat, pooled, weighed, and homogenized manually with a glass potter in 600 PL of a 5% formic acid- Western blot analysis. The whole inner medulla from each kidney was dissected on ice and was homogenized manually with a glass potter in 500 PL of PBS containing protease inhibitors (Complete Mini EDTA-free, Roche). Homogenate protein concentration was determined by the Bradford method (Biorad). Samples were then solubilized in Laemmli buffer and heated at 65°C for 10 min. Equal protein amounts (5 Pg/lane) were separated by 12% SDS-PAGE and transferred to PVDF membranes.
Blots were blocked with PBS supplemented with 5% nonfat dry milk, then incubated with the primary antibody (1 h at room temperature). AQP2 was detected with an affinity purified polyclonal antibody raised against the carboxy-terminus of peptide sequence of rat AQP2 (11, 12, 35). The phosphorylated form of AQP2 (p-AQP2) was revealed with a specific antibody directed against AQP2 phosphorylated Statistics. Results were expressed as means ± SE. Differences between control and thirsted rats at both ages were analyzed by one-way ANOVA. Differences were considered significant for P < 0.05.
RESULTS
Water balance and urine osmolality. The age-related polyuria was confirmed in senescent 30-mo-old female WAG-Rij rats, which exhibited significantly higher urine flow rate and reduced urinary osmolality, as compared to younger animals ( Table 1 ). The protocol of WD caused a dramatic fall of urinary flow rate and a doubling of urine osmolality in both age groups (Table 1) . Consistently with a lower average papilla osmolality, urine concentration remained significantly lower in senescent than in adult rats following WD. Urea concentration plays a significant role in the papillary osmolality defect with aging since it is markedly lower in senescent animals ( Table 1, 47) . Average papillary urea concentration was increased by WD but remained also significantly lower in water deprived senescent rats compared to adult ones. However, the fraction of urea to papillary osmolality, which was significantly lower with aging (25 and 17% in 10-and 30-mo-old rats, respectively), increased to comparable levels after WD in both age groups (34 and 31% in 10-and 30-mo-old rats, respectively).
Statistical analysis revealed that the final urine concentration in all the animals was best correlated to the average urea concentration in the papilla rather than to average papillary osmolality or to papillary urea fraction.
AVP and plasma osmolality concentration. As expected, aging had no effect on plasma AVP level in the basal state (Table 2) . We found that WD induced a six-fold increase in plasma AVP in both groups (Table 2 ). In thirsted 30-mo-old rats, plasma osmolality was significantly increased ( Table 1 ), demonstrating that WD resulted in dehydration in senescent animals.
Papilla cAMP and cGMP contents. The cAMP response of adult rats injected 30 min before sacrifice with dDAVP -a specific agonist of V 2 receptor-was tested by enzyme immunoassay. As expected, a significant 60% increase in papillary cAMP was measured in dDAVP-injected animals (524 ± 64 pmol/g wet tissue vs. 326 ± 32 pmol/g in uninjected animals, P < 0.002). As shown in Table   2 and previously (11, 35), aging did not modify cAMP content level in the inner medulla. Surprisingly, despite a marked increase of plasma AVP, papillary cAMP was not significantly higher in water deprived animals (Table 2 ). This suggests that response to AVP results in a transitory intracellular cAMP increase but not in significant long-term cAMP stimulation. In addition, cGMP content level was identical in 10-and 30-mo-old rats in control condition and was not significantly different following WD (Table 2) or acute dDAVP injection (data not shown).
AQP2 and p-AQP2 protein expression. Fig. 1 shows AQP2 and p-AQP2 protein expression in the inner medulla by Western blotting. Wells were loaded with equal amounts of protein and no significant difference was seen between samples on Coomassie stained blots. Following WD, both AQP2 and p-AQP2 expression hugely increased in the inner medulla of adult (Fig. 1A ) and senescent rats (Fig. 1B) and finally resulted in comparable, elevated levels of AQP2 and p-AQP2 in 10-and 30-mo-old rats (Fig. 1C) . Semi-quantitative analysis of the blots demonstrated that WD resulted in dramatic and highly significant increase in AQP2 (Fig. 1D ) and p-AQP2 (Fig. 1E ) expression in both age groups. In baseline condition, AQP2 expression level was significantly different between 10-and 30-mo-old rats. Following WD, AQP2 protein level was no longer significantly different with aging (Fig. 1D) . The regulation of p-AQP2 exhibited exactly the same behavior as that of AQP2 (Fig. 1E) .
AQP2 subcellular localization. AQP2 localization in IMCD cells was performed by indirect immunofluorescence. In control adults, AQP2 showed punctuate intracellular staining throughout IMCD cells (Fig. 2a) , including the basolateral side (arrowhead). Following WD, most staining for AQP2 was on the apical side of IMCD cells (Fig. 2b) . In senescent rats, AQP2 staining was intracellular ( Fig. 2c) and variable between tubules: in some tubules, AQP2 was hardly detectable (Fig.   2c , *). After WD, AQP2 in senescent rats was evenly distributed among IMCD cells and tubules and was markedly redistributed along the apical membrane (Fig. 2d) .
Phosphorylated AQP2 (p-AQP2) subcellular localization. Staining for AQP2 phosphorylated at
Ser 256 (p-AQP2), selectively recognized by a specific antibody, exhibited an apical localization in adult rats (Fig. 3a) . Following WD, p-AQP2 remained localized in the apical region of cells (Fig. 3b) .
In senescent animals, p-AQP2 staining was weaker and heterogenous (Fig. 3c) . In this age group, p-AQP2 exhibited punctuate staining in the apical region of IMCD cells (Fig. 3c, inset) . After WD, p-AQP2 in 30-mo-old rats increased and showed a continuous staining along the apical region of the cells, like in 10-mo-old animals (Fig. 3d) .
Altogether, these data show that, in response to WD, AQP2 and p-AQP2 proteins were upregulated and suggest that AQP2 was translocated to the plasma membrane of IMCD cells in waterdeprived 10-and 30-mo-old rats. Finally, a two day-WD resulted in a complete correction of expression and localization of both AQP2 and p-AQP2 in senescent animals. Interestingly, AQP2 mRNA was significantly increased in the outer medulla of old rats (ratio = 1.41, P = 0.04), where AQP2 is less downregulated by aging than in the IMCD (35). Thus, the impaired AQP2 protein expression of senescent rats appears as a posttranscriptional defect, which is not restricted to the inner medulla, but which is compensated for by higher AQP2 mRNA levels in the outer medulla.
DISCUSSION
The reduced concentrating ability of aging kidney in rats has been associated with underexpression and mistrafficking of AQP2 in IMCD principal cells (11, 35, 46). In senescent female WAG/Rij rats, this defect is independent of AVP secretion (17, 25, 35) and the AVP signaling pathway (12, 35). Instead, previous studies have suggested that the threshold for AQP2 regulation by AVP is increased with aging (11, 12). Since AQP2 expression and localization can also be regulated by AVP-independent pathways, as observed in dehydrated rats supplemented with V 2 -receptor antagonist (28), we investigated the responsiveness of old female WAG/Rij rats to WD.
A two day-WD elicited a two-fold concentration of urine osmolality and a marked fall in urine output in 10-and 30-mo-old animals. However, after WD, senescent female WAG/Rij rats exhibited a higher urine flow rate and a reduced urinary osmolality than adults. Consequently, WD resulted in dehydration in old rats, as shown by their higher plasma osmolalities. This is consistent with the impaired response to WD with aging reported in Fischer 344 rats (3) and humans (38). Nevertheless, WD induced a dramatic and highly significant upregulation of the expression of both AQP2 and its phosphorylated form (p-AQP2) in 10-and 30-mo-old rats. AQP2 upregulation by WD is in agreement with previous studies (29, 31, 46) but was not seen in old male F344BNF1 rats, which did not increase their urine osmolality either (7, 43). Strain differences in the aging process and related diseases, such as pituitary tumors or chronic progressive nephropathy, with an impaired AVP secretion, probably explain this difference.
Our data show that trafficking of AQP2 was corrected by WD in 30-mo-old animals. At the baseline condition, AQP2 was distributed throughout IMCD cells, including the basolateral side in adults. In senescent rats, the staining was scarce and mostly on the apical side. As expected, p-AQP2 was on the apical side only in 10-and 30-mo-old animals. Following WD, AQP2 and p-AQP2 exhibited a continuous staining along the apical side of cells in both age groups.
In our model, the remaining defect in kidney concentrating ability of thirsted senescent animals is independent of AQP2 regulation but can likely be attributed to a lower driving force for water reabsorption along IMCD, where the final concentration of urine occurs. Indeed, the papillary osmolality remains significantly lower after WD in old animals as compared to adults. conditions. Interstitial tonicity has also been suggested to regulate AQP2, through transcription activation (16, 21, 42). Indeed, Umenishi et al. (48) observed that hyperosmolality enhances the apical insertion of nonglycosylated AQP2 via a cAMP-and PKA-independent regulation pathway. In our studies, low AQP2 expression in senescent animals is associated to a reduced papillary osmolality.
WD induced a tremendous increase in AQP2 protein expression in both age groups, despite lower papillary osmolality in old rats as compared to adults. However, urea contribution to papillary osmolality was increased by WD to comparable levels between adult and senescent rats (34 and 31%, respectively). These observations suggest that urea fraction in papillary osmolality, but not total osmolality, may be involved in AQP2 upregulation during WD.
To investigate further the mechanism of AQP2 misregulation with aging, we quantified, by real-time RT-PCR, changes in AQP2 mRNA levels. In agreement with another study, made by microarray and RT-PCR but in the whole kidney (36), AQP2 mRNA was not significantly different between young and senescent rats in the IMCD. However, in the outer medulla, where AQP2 protein expression is only slightly downregulated with aging (35), AQP2 mRNA was significantly higher in senescent animals than in controls. These results suggest either a defect in translation or in the stability of the AQP2 protein with aging in the kidney medulla of WAG/Rij rats. Uncoupling between AQP2 mRNA and protein is unusual: in most cases, the AQP2 protein is directly modulated by AQP2 mRNA levels.
To our knowledge, only one other study reports that polyuria in hypercalcemic rats is accompanied in the IMCD by a decreased expression of AQP2 protein, but not mRNA (40). Such a dissociation between transcript and protein levels has already been reported for other proteins (19, 23). In the context of aging, one study reported recently a differential expression of the fragile X retardation protein (FMRP) and its transcript in mice brain during aging (41). In human kidney, Eikmans et al.
found increased mRNA level with aging for collagen IV, whereas the protein expression was unchanged (15). Our results and these examples underscore the importance of proteomic approaches Accordingly, in the present study, AQP2 protein expression is correlated with the urea fraction in total papillary osmolality.
In conclusion, we show that senescent female WAG/Rij rats were able to increase their urinary concentrating ability in response to WD. However, after WD, urinary osmolality remains significantly lower with aging, in correlation with lower urea concentration in the papilla. Expression of AQP2 and p-AQP2, which is remarkably low in old animals, was hugely increased by WD. This resulted in similar AQP2 and p-AQP2 expression levels between age groups after WD. AQP2 mistargeting in senescent rats was corrected by WD, through improved phosphorylation of the protein, as shown by the apical localization of p-AQP2. In addition, we report that AQP2 protein downregulation with aging does not result from decreased AQP2 mRNA. In the outer medulla, AQP2 transcripts actually increase mean ± SE of 6-8 rats. * P < 0.05, NS: no significantly different, n: number of rats. Plasma AVP Concentration (pg/mL) n = 6
Papillary cAMP content (pmol/g papilla) n = 6
Papillary cGMP content (pmol/g papilla) n = 6 Control: 10-mo-old 1.4  0.2 291  70 7.2  0.9 30-mo-old 1.7  0.2 288  24 9.0  2.3 WD: 10-mo-old 10.9  0.6 † 317  24 5.7  0.7 30-mo-old 10  1 † 355  36 5.1  0.3 Values are means  SE. n, number of animals. † P < 0.05 vs. control rats at the same age. Differences were not statistically significant vs. 10-mo-old rats in the same group (Control or WD), as well as for cAMP and cGMP papillary contents in all conditions.
